Grant Abb Vie Inc. Transaction History

Grant

$192 Million
Q2 2024

A detailed history of Grant transactions in Abb Vie Inc. stock. As of the latest transaction made, Grant holds 9,347 shares of ABBV stock, worth $1.81 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

9,347

Previous 9,355 0.09%

Holding current value

$1.81 Million

Previous $1.7 Million 5.87%

% of portfolio

0.83%

Previous 0.89%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $1,238 - $1,446	-8 Reduced 0.09%	9,347 $1.6 Million
Q1 2024 Apr 25, 2024	SELL	$159.82 - $182.1 $324,914 - $370,209	-2,033 Reduced 17.85%	9,355 $1.7 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $319,094 - $359,375	-2,319 Reduced 16.92%	11,388 $1.76 Million
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $231,912 - $268,472	-1,736 Reduced 11.24%	13,707 $2.04 Million
Q2 2023 Jul 19, 2023	SELL	$132.51 - $164.9 $140,063 - $174,299	-1,057 Reduced 6.41%	15,443 $2.08 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $51,770 - $59,621	-358 Reduced 2.12%	16,500 $2.63 Million
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $5,117 - $6,137	37 Added 0.22%	16,858 $0
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $444,637 - $509,970	3,313 Added 24.53%	16,821 $2.52 Million
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $550 - $699	4 Added 0.03%	13,508 $2.06 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $271,086 - $336,342	2,054 Added 17.94%	13,504 $2.11 Million
Q4 2021 Jan 13, 2022	BUY	$107.43 - $135.93 $59,086 - $74,761	550 Added 5.05%	11,450 $1.57 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $43,170 - $47,525	422 Added 4.03%	10,900 $1.22 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $843,374 - $1.14 Million	10,478 New	10,478 $1.18 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.

Account